Rachel Brandeis - Concepedia

Author

Rachel Brandeis

Israel Institute for Biological Research

Also Known As

R Brandeis, R. BRANDEIS, R. Brandeis, RACHEL BRANDEIS, Rachel Brandeis

Publications

2.7K

Citations

H-Index

Concepts

All Affiliations

Israel Institute for Biological Research Tel Aviv University Hebrew University of Jerusalem Rappaport Family Institute for Research in the Medical Sciences Bar-Ilan University

About

Rachel Brandeis is an author at Israel Institute for Biological Research specializing in medicine, neuroscience, and social sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	22	940
2	Social Sciences	12	14	835
3	Health Sciences	2	2	72
4	Anesthesia	2	2	25
5	Natural Sciences	1	1	18

Rachel Brandeis

Publications

1.7K

Citations

H-Index

Page 1

	Year	Citations
Age-related structural changes in the rat hippocampus: correlation with working memory deficiency Tamar Kadar, Michael Silbermann, Rachel Brandeis, Brain Research Rat HippocampusCognitive ScienceMemory DeficiencyAgingBrain Function	1990	149
Ocular injuries following sulfur mustard exposure—Pathological mechanism and potential therapy Tamar Kadar, Shlomit Dachir, Liat Cohen, Toxicology Ocular InjuriesOphthalmologyPoisoningToxicologyOcular Pathology	2008	139
Prevention of soman-induced cognitive deficits by pretreatment with human butyrylcholinesterase in rats Rachel Brandeis, Lily Raveh, Jacob Grunwald, Pharmacology Biochemistry and Behavior NeuropsychologyHuman ButyrylcholinesteraseMedicinePsychopharmacologyNeuropharmacology	1993	83
enhances neuronal death following transient forebrain ischemia in gerbils Ben Avi Weissman, Tamar Kadar, Rachel Brandeis, Neuroscience Letters NeurophysiologyNeuroanatomySocial SciencesNeuroprotectionNeurology	1992	80
AF150(S) and AF267B Abraham Fisher, Rachel Brandeis, Rachel Haring Nira Bar-Ner, Journal of Molecular Neuroscience Uncrewed Aircraft SystemsStandardizationSpecification (Technical Standard)	2002	80
AF710B, a Novel M1/σ1 Agonist with Therapeutic Efficacy in Animal Models of Alzheimer's Disease Abraham Fisher, Ilya Bezprozvanny, Lili Wu, Neurodegenerative Diseases Synaptic TransmissionExperimental PharmacologySynaptic SignalingSocial SciencesNeuroinflammation	2015	79
(+-)-cis-2-methyl-spiro(1,3-oxathiolane-5,3')quinuclidine, an M1 selective cholinergic agonist, attenuates cognitive dysfunctions in an animal model of Alzheimer's disease. Abraham Fisher, Rachel Brandeis, Ishai Karton, Journal of Pharmacology and Experimental Therapeutics	1991	78
Reversal of age-related cognitive impairments by an M1 cholinergic agonist, AF102B Rachel Brandeis, Shlomit Dachir, Michal Sapir, Pharmacology Biochemistry and Behavior NeuropsychologyAlzheimer's DiseaseAge-related Cognitive ImpairmentsBrain FunctionVascular Cognitive Disorder	1990	75
(±)-cis-2-Methyl-spiro(1,3-oxathiolane-5,3′) quinuclidine (AF102B): A new M1 agonist attenuates cognitive dysfunctions in AF64A-treated rats Abraham Fisher, Rachel Brandeis, Zipora Pittel, Neuroscience Letters Af64a-treated RatsMolecular PharmacologyMedicinePsychopharmacologyPharmacological Agent	1989	73
M<sub>1</sub> Muscarinic Agonist Treatment Reverses Cognitive and Cholinergic Impairments of Apolipoprotein E‐Deficient Mice Abraham Fisher, Rachel Brandeis, Shira Chapman, Journal of Neurochemistry	1998	72

Page 1